TARGET
saveBCMA
Multiple myeloma plasma-cell antigen.
also known as: tnfrsf17, b-cell maturation antigen
drugs
0
catalysts
0
news
50
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes upbiospace · 3d ago
- J&J, Legend tout long-term survival benefits for Carvykti in multiple myelomabiospace · 15d ago
- GSK doubles down on Chimagen with $750M multiple myeloma wagerfiercebiotech · 26d ago
- Unlocking cell surface protein research with site-specific labelingbiospace · 27d ago
- BMS clinches pivotal win for myeloma CAR T in ‘key derisking event’biospace · 1mo ago
- Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapybiopharma dive · 1mo ago
- Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpointfiercebiotech · 1mo ago
- AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma studybiospace · 1mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that